Novo Nordisk Looks Beyond Weight Loss to Longevity and Aesthetics

Novo's blockbuster drugs could pull it into buzzier areas of healthcare, chief executive Mike Doustdar said, as the Ozempic maker seeks to l

Zum Angebot